{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.3616.200.110.102.6087",
  "meta" : {
    "versionId" : "9",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "Clinical Architecture"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2023-06-21"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2022-07-27"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.6087",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.3.3616.200.110.102.6087"
    }
  ],
  "version" : "20220727",
  "name" : "COVID19SNOMEDValueSetForCOVID19Vaccination",
  "title" : "COVID19 SNOMED Value Set for COVID19 Vaccination",
  "status" : "retired",
  "experimental" : false,
  "date" : "2023-06-21T18:16:37-04:00",
  "publisher" : "Clinical Architecture",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: This set of values contains terms related to COVID-19 vaccination.),(Data Element Scope: ),(Inclusion Criteria: Includes SARS-CoV-2 vaccination.),(Exclusion Criteria: )",
  "compose" : {
    "include" : [
      {
        "system" : "http://snomed.info/sct",
        "concept" : [
          {
            "code" : "1119350007",
            "display" : "Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)"
          },
          {
            "code" : "1144997007",
            "display" : "Administration of first dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)"
          },
          {
            "code" : "1144998002",
            "display" : "Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)"
          },
          {
            "code" : "1156257007",
            "display" : "Administration of vaccine product against severe acute respiratory syndrome coronavirus 2 (procedure)"
          },
          {
            "code" : "1157107003",
            "display" : "Administration of vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (procedure)"
          },
          {
            "code" : "1157108008",
            "display" : "Administration of second dose vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (procedure)"
          },
          {
            "code" : "1157196000",
            "display" : "Administration of vaccine product containing only inactivated whole severe acute respiratory syndrome coronavirus 2 antigen (procedure)"
          },
          {
            "code" : "1157197009",
            "display" : "Administration of second dose of vaccine product containing only inactivated whole severe acute respiratory syndrome coronavirus 2 antigen (procedure)"
          },
          {
            "code" : "1162645008",
            "display" : "Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure)"
          },
          {
            "code" : "1162646009",
            "display" : "Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure)"
          },
          {
            "code" : "1179496000",
            "display" : "Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (procedure)"
          },
          {
            "code" : "1179497009",
            "display" : "Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (procedure)"
          },
          {
            "code" : "1193583000",
            "display" : "Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein (procedure)"
          },
          {
            "code" : "840534001",
            "display" : "Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:336060be-4aa6-48ad-8a1a-bb4b6e4063d2",
    "timestamp" : "2024-06-14T16:21:43-04:00",
    "total" : 14,
    "contains" : [
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "1119350007",
        "display" : "Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "1144997007",
        "display" : "Administration of first dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "1144998002",
        "display" : "Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "1156257007",
        "display" : "Administration of vaccine product against severe acute respiratory syndrome coronavirus 2 (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "1157107003",
        "display" : "Administration of vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "1157108008",
        "display" : "Administration of second dose vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "1157196000",
        "display" : "Administration of vaccine product containing only inactivated whole severe acute respiratory syndrome coronavirus 2 antigen (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "1157197009",
        "display" : "Administration of second dose of vaccine product containing only inactivated whole severe acute respiratory syndrome coronavirus 2 antigen (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "1162645008",
        "display" : "Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "1162646009",
        "display" : "Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "1179496000",
        "display" : "Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "1179497009",
        "display" : "Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "1193583000",
        "display" : "Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "840534001",
        "display" : "Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)"
      }
    ]
  }
}
